Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Cell Count × Other hematologic neoplasm × Clear all

Phase

Phase 1 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Plasma cell 1 Other hematologic neoplasm 1 Head & Neck 1

Conditions

Hematologic Neoplasms 1

Interventions

Cyclophosphamide 345 Cytarabine 289 fludarabine phosphate 188 Rituximab 175 fludarabine 163 Methotrexate 156 Azacitidine 151 venetoclax 142 Busulfan 140 Filgrastim 119 Mycophenolic Acid 118 Whole-Body Irradiation 116 Etoposide 114 Peripheral Blood Stem Cell Transplantation 113 Tacrolimus 105 Melphalan 93 Vincristine 90 Dexamethasone 88 Cyclosporine 84 Imatinib Mesylate 79 Antilymphocyte Serum 77 Granulocyte Colony-Stimulating Factor 76 Radiotherapy 75 Decitabine 73 Daunorubicin 73 Dasatinib 64 Doxorubicin 60 Lenalidomide 59 Idarubicin 58 Clofarabine 55

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01186809 2019-01-23

CIK2

A.O. Ospedale Papa Giovanni XXIII

Phase 2 Completed

74 enrolled 6 charts

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡